These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20042756)

  • 21. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    van Zanten AR; Bakker J; van den Berg PC; Girbes AR; van Leeuwen SJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1179. PubMed ID: 11433670
    [No Abstract]   [Full Text] [Related]  

  • 22. [Re-administration of drotrecogin alfa activated in a patient with episodes of severe sepsis].
    Verdú MT; Sánchez OJ
    Rev Esp Anestesiol Reanim; 2007 Dec; 54(10):637-8. PubMed ID: 18201006
    [No Abstract]   [Full Text] [Related]  

  • 23. Drotrecogin alfa: a role in emergency department treatment of severe sepsis?
    McLeay AM
    Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Still puzzled by additional data from the PROWESS study.
    Schultz MJ
    Crit Care Med; 2005 Sep; 33(9):2146; author reply 2146-7. PubMed ID: 16148509
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical impact of novel anticoagulation strategies in sepsis.
    Opal SM
    Curr Opin Crit Care; 2001 Oct; 7(5):347-53. PubMed ID: 11805532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breakthrough found in treatment of severe sepsis.
    Clin Resour Manag; 2001 Jul; 2(7):107-9. PubMed ID: 11482248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly.
    Eichacker PQ; Natanson C; Danner RL
    N Engl J Med; 2006 Oct; 355(16):1640-2. PubMed ID: 17050887
    [No Abstract]   [Full Text] [Related]  

  • 28. An unusual cause of multiple cerebral hemorrhages: drotrecogin alpha (activated protein C).
    Algin O; Ceylan G; Kilic E
    AJNR Am J Neuroradiol; 2011 May; 32(5):E85-6. PubMed ID: 20395392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of anticoagulants in patients with sepsis.
    Langer M; Riccardi F; Piovella F; Klersy C
    JAMA; 2002 Jan 23-30; 287(4):448-9. PubMed ID: 11798358
    [No Abstract]   [Full Text] [Related]  

  • 30. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
    Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
    Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. My brother has severe sepsis--should he receive Xigris?
    Suter PM
    Minerva Anestesiol; 2007 Dec; 73(12):647-50. PubMed ID: 18046295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Activated protein C, coagulation, inflammation, and treatment of severe sepsis].
    van Deventer SJ; Pajkrt D
    Ned Tijdschr Geneeskd; 2001 Mar; 145(13):613-6. PubMed ID: 11305209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of severe sepsis and multiple organ failure with activated protein C].
    Strøm JJ
    Ugeskr Laeger; 2004 Mar; 166(11):995. PubMed ID: 15049233
    [No Abstract]   [Full Text] [Related]  

  • 34. Postoperative septic shock.
    Jenkins I
    Cleve Clin J Med; 2006 Jul; 73(7):607; author reply 607-8. PubMed ID: 16845972
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of activated protein C in the pathophysiology of severe sepsis.
    Dettenmeier P; Swindell B; Stroud M; Arkins N; Howard A
    Am J Crit Care; 2003 Nov; 12(6):518-24; quiz 525-6. PubMed ID: 14619357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kigris. FDA approves first biologic for sepsis.
    Nursing; 2002 Feb; 32(2):18. PubMed ID: 11924158
    [No Abstract]   [Full Text] [Related]  

  • 37. [Human recombinant activated protein C in patients with severe sepsis and septic shock].
    Segal E
    Harefuah; 2002 Feb; 141(2):130-1. PubMed ID: 11905079
    [No Abstract]   [Full Text] [Related]  

  • 38. Should we be using activated protein C to treat severe sepsis?
    Eve RL; Duffy MR
    Br J Hosp Med (Lond); 2009 Aug; 70(8):484. PubMed ID: 19684544
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinant activated protein C: decisions for administration.
    Dellinger RP
    Crit Care Med; 2006 Feb; 34(2):530-1. PubMed ID: 16424737
    [No Abstract]   [Full Text] [Related]  

  • 40. Activated protein C for severe sepsis.
    Ely EW; Bernard GR; Vincent JL
    N Engl J Med; 2002 Sep; 347(13):1035-6. PubMed ID: 12324564
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.